A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) has become the dominant type of esophageal cancer in United States. The 5-year survival rate of EAC is below 20% and most patients present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Md. Sazzad, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321464/
https://www.ncbi.nlm.nih.gov/pubmed/28225784
http://dx.doi.org/10.1371/journal.pone.0171824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321464/
https://www.ncbi.nlm.nih.gov/pubmed/28225784
http://dx.doi.org/10.1371/journal.pone.0171824

Ejemplares similares